Grupo SURA invests USD 100m in VaxThera vaccine factory
Grupo SURA invierte USD 100m en fábrica de vacunas VaxThera
Intel ID : 392213
|
||||
| Intel ID | 392213 | |
| Value | EUR 92,11m | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
|
Financial Data - Grupo SURA
(31 Dec 2015) |
Revenue: EUR 294,82m Exchange Rate:
|
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies (Primary) 25 Financial Services / 25.04 Other Financial Services |
|
| Secondary Subsectors (TTRSC) |
25.01.01 Asset Management 25 Financial Services / 25.01 Banking & Investment |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.01 Asset Management 25 Financial Services / 25.01 Banking & Investment |
||
| Secondary Sectors (TTRSC) |
25.02.05 Multiline Insurance Providers 25 Financial Services / 25.02 Insurance |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.